JETRO AnnouncementsApply Now: Regenerative medicine companies for Japan Entry Acceleration Program 2026
Jul 01, 2026
JEAP, short for the Japan Entry Acceleration Program, is built on the idea of turning bold visions into real opportunities. The program represents creativity without limits, fresh beginnings in Japan, and the energy to connect globally and grow faster.
With this spirit at its core, JEAP invites pioneering companies in regenerative medicine to join us in shaping the future of healthcare in Japan.
As part of JEAP, selected companies gain access to Japan’s business ecosystem, from tailored mentorship and market insights to direct connections with leading CDMOs/CROs and Pharmaceutical companies.
With the support of Forum for Innovative Regenerative Medicine (FIRM) this year, we will provide comprehensive support needed to accelerate market entry, collaboration, and growth in one of the world’s most advanced markets.
Organized by
Supported by
CONTENTS
| Program Name | Japan Entry Acceleration Program 2026 |
|---|---|
| Program Period | November 1 2026- February 20 2027 (TBD) |
| Application Period |
July 1 2026 - October 16 2026* (TBD) Applications submitted by Aug 16 will be reviewed first, with at least 5 companies selected in this phase. Subsequent applications (Aug 17 onward) will be considered for the remaining slots. The application window may close early once the cohort reaches approximately 10 companies. For more details on the selection process, see the program brochure above. |
| Capacity | Approx. 10 companies |
| Location | The program will be held mainly online, with Site Visits & Demo Day taking place in person in Tokyo and Osaka. |
| Eligibilities |
|
| Selection Schedule | Screening will be conducted on a rolling basis, beginning as soon as applications open. Results will be communicated to all applicants by October 16. We appreciate your patience during this time. For more information on the selection process, please refer to the program brochure above. |
| Program Content |
|
| Participation fee |
Free of charge. Note:
|
| Organizer | JETRO |
| Supporter | Forum for Innovative Regenerative Medicine (FIRM) |
How to Apply
Please provide the required information in the application form below.
Appliction deadline
Friday, October 16. 2026 23:59
Contact us
JETRO Investment and Alliance Division, Innovation Department (in charge: Saito, Ishizuna, Ono)
E-mail: ive@jetro.go.jp Tel: 03-3582-5644
Is Japan Your Next Life Sciences Growth Market?
Contact Us
Investing in and collaborating with Japan
We will do our very best to support your business expansion into and within Japan as well as business collaboration with Japanese companies. Please feel free to contact us via the form below for any inquiries.
Inquiry FormJETRO Worldwide
Our network covers over 50 countries worldwide. You can contact us at one of our local offices near you for consultation.
Worldwide Offices


